Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation

The purpose of this work was to determine whether the outcome of patients with transformed indolent lymphoma improved if they, after R-chemo, also received upfront autologous stem-cell transplantation. Upfront autologous stem-cell transplant improved the outcome in sequential, but not composite/disc...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of oncology Vol. 26; no. 2; pp. 393 - 399
Main Authors:	Madsen, C., Pedersen, M.B., Vase, M.Ø., Bendix, K., Møller, M.B., Johansen, P., Jensen, B.A., Jensen, P., Munksgaard, L., Brown, P.D., Segel, E.K., d'Amore, F.A.
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-02-2015
Subjects:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use autologous stem-cell transplantation Cell Transformation, Neoplastic - pathology Combined Modality Therapy - methods Disease-Free Survival Female Hematopoietic Stem Cell Transplantation - methods Humans Lymphoma - mortality Lymphoma - pathology Lymphoma - therapy Male Middle Aged Rituximab - administration & dosage rituximab era transformed indolent lymphoma Transplantation, Autologous rituximab era transformed indolent lymphoma autologous stem-cell transplantation
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!